Feed aggregator

EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk

Biospace news - Wed, 09/04/2024 - 02:00
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk 4/9/2024

AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report

Biospace news - Wed, 09/04/2024 - 02:00
AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report 4/9/2024

Lilly Pays $3.2B to Buy Morphic and Deepen Immunology, Gastro Portfolio

Biospace news - Wed, 08/07/2024 - 02:00
Lilly Pays $3.2B to Buy Morphic and Deepen Immunology, Gastro Portfolio 7/8/2024

Grifols Gets $6B Takeover Offer from Founding Family, Brookfield to Go Private

Biospace news - Wed, 08/07/2024 - 02:00
Grifols Gets $6B Takeover Offer from Founding Family, Brookfield to Go Private 7/8/2024

Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing

Biospace news - Wed, 08/07/2024 - 02:00
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing 7/8/2024

GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study

Biospace news - Wed, 08/07/2024 - 02:00
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study 7/8/2024

Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo

Biospace news - Wed, 08/07/2024 - 02:00
Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo 7/8/2024

Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling

Biospace news - Wed, 08/07/2024 - 02:00
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling 7/8/2024

Beyond GLP-1s: The Next Obesity Treatments

Biospace news - Wed, 08/07/2024 - 02:00
Beyond GLP-1s: The Next Obesity Treatments 7/8/2024

Drug Developers Tap the Immune System to Supercharge ADCs

Biospace news - Wed, 08/07/2024 - 02:00
Drug Developers Tap the Immune System to Supercharge ADCs 7/8/2024

Patient Assistance Programs: A Source of Real-World Data?

Biospace news - Wed, 08/07/2024 - 02:00
Patient Assistance Programs: A Source of Real-World Data? 7/8/2024

Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids

Biospace news - Mon, 08/05/2024 - 02:00
Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids 5/8/2024

ASGCT2024: FDA’s Marks on Accelerated Approval, Gene Therapy Costs and More

Biospace news - Mon, 08/05/2024 - 02:00
ASGCT2024: FDA’s Marks on Accelerated Approval, Gene Therapy Costs and More 5/8/2024

Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy

Biospace news - Mon, 08/05/2024 - 02:00
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy 5/8/2024

AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters

Biospace news - Mon, 08/05/2024 - 02:00
AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters 5/8/2024

Pfizer Halts Dosing in Late-Stage DMD Study Following Death of Young Patient

Biospace news - Mon, 08/05/2024 - 02:00
Pfizer Halts Dosing in Late-Stage DMD Study Following Death of Young Patient 5/8/2024

Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcomm

Biospace news - Mon, 08/05/2024 - 02:00
Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcomm 5/8/2024

ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird

Biospace news - Mon, 08/05/2024 - 02:00
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird 5/8/2024

Generative AI Finds Its Footing in Drug Development

Biospace news - Mon, 08/05/2024 - 02:00
Generative AI Finds Its Footing in Drug Development 5/8/2024

BMS, J&J Losses Not the End of IRA Legal Battle

Biospace news - Mon, 08/05/2024 - 02:00
BMS, J&J Losses Not the End of IRA Legal Battle 5/8/2024